4BASEBIO UK SOCIETAS (4BB) — Financial Flexibility Index
4BASEBIO UK SOCIETAS (4BB) has a Financial Flexibility Index of -0.41x as of June 2025. Free cash flow of GBX-7.32 Million (operating CF GBX-7.64 Million minus capex GBX322.00K) represents 0% of total liabilities (GBX17.89 Million). Check 4BASEBIO UK SOCIETAS strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
4BASEBIO UK SOCIETAS Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for 4BASEBIO UK SOCIETAS across 6 annual periods. See 4BASEBIO UK SOCIETAS (4BB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for 4BASEBIO UK SOCIETAS (2019–2024)
Year-by-year free cash flow to debt coverage for 4BASEBIO UK SOCIETAS. For the full company profile including market capitalisation, see 4BASEBIO UK SOCIETAS market capitalisation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.50x | GBX-9.17 Million | GBX-10.74 Million | GBX18.35 Million | ▼ -32.4% |
| 2023 | -0.38x | GBX-4.69 Million | GBX-6.18 Million | GBX12.41 Million | ▲ +37.6% |
| 2022 | -0.60x | GBX-2.76 Million | GBX-4.70 Million | GBX4.57 Million | ▼ -48.1% |
| 2021 | -0.41x | GBX-1.23 Million | GBX-2.74 Million | GBX3.01 Million | ▼ -455.0% |
| 2020 | -0.07x | GBX-173.00K | GBX-1.02 Million | GBX2.35 Million | ▼ -239.5% |
| 2019 | -0.02x | GBX-66.00K | GBX-269.00K | GBX3.04 Million | — |